Sagimet Biosciences Inc.
SGMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,908 | -$10,386 | -$18,176 | -$16,201 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,598 | $1,472 | $1,534 |
| Change in WC | $701 | -$125 | -$726 | $3,662 |
| Other Non-Cash | $2,027 | -$188 | $2,894 | -$19 |
| Operating Cash Flow | -$10,180 | -$9,101 | -$14,536 | -$11,024 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$31,260 | -$42,953 | -$15,575 | -$13,758 |
| Inv. Sales/Matur. | $31,335 | $29,663 | $18,988 | $23,608 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $75 | -$13,290 | $3,413 | $9,850 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $274 | $1 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $274 | $1 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,831 | -$22,390 | -$11,123 | -$1,174 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42,327 | $64,717 | $75,840 | $77,014 |
| End Cash | $32,496 | $42,327 | $64,717 | $75,840 |
| Free Cash Flow | -$10,180 | -$9,101 | -$14,536 | -$11,024 |